Showing results (1481-1490 of 1,725) with videos related to

Sort By:
Pageof 173
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 17, 2024
Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative StudyS Collinson, S Ingram-Walpole, C Jackson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxelU A Nitz, O Gluz, M Christgen, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Oncoimmunology|November 18, 2016
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitopeP Baumgaertner, C Costa Nunes, A Cachot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
The Plant Cell|July 29, 2021
Maize Brittle Stalk2-Like3, encoding a COBRA protein, functions in cell wall formation and carbohydrate partitioningBenjamin T Julius, Tyler J McCubbin, Rachel A Mertz, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 14, 2023
Maternal and newborn metabolomic changes associated with urinary polycyclic aromatic hydrocarbon metabolite concentrations at delivery: an untargeted approachJagadeesh Puvvula, Kathrine E Manz, Joseph M Braun, et al.
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Environmental Health Perspectives|June 7, 2023
Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMIYun Liu, Adaeze C Wosu, Abby F Fleisch, et al.
Pageof 173